author-photo

Hidenori Urata

Fukuoka University

211

Papers

7045

Citations

Citation Trend

Filter By

Papers (153) Sort By

Journal Conference Others

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

2021 Hypertension Research
Show All
- Source
- Cite
- Save
Citations (3)
Preliminary Observations on the Antihypertension Action of Dabigatran Etexilate in Patients With Nonvalvular Atrial Fibrillation: A Prospective Multicenter Single-Arm Interventional Study

2020 cardiology research
- Tomohiko Yamamoto
- Hidenori Urata
Show All
- Source
- Cite
- Save
Citations (0)
Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

2020 Journal of Clinical Medicine Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P196: Chymase Inhibition: Is It An Ideal Target For Controlling Salt-Induced Hypertension?

2020 Hypertension
Show All
- Source
- Cite
- Save
Citations (0)
Add-on aliskiren treatment can decrease blood pressure but requires attention to risks of renal impairment and hyperkalemia Chikushi Anti-Hypertension Trial-Rasilez® (CHAT-Ras)

2020 Clinical and Experimental Hypertension
Show All
- Source
- Cite
- Save
Citations (0)
Increase of chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes after acute myocardial infarction chymase activity after acute myocardial infarction

2019 Heart and Vessels
Show All
- Source
- Cite
- Save
Citations (4)
Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”

2019 Clinical and Experimental Hypertension
Show All
- Source
- Cite
- Save
Citations (1)
Simplifying adrenal vein sampling for cardiologists “In the New Era of Catheter Treatment for Hypertension”

2019 Hypertension Research
- Keisuke Okamura
- Hidenori Urata
Show All
- Source
- Cite
- Save
Citations (1)
Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)

2019 Clinical and Experimental Hypertension
Show All
- Source
- Cite
- Save
Citations (3)
Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study

2019 Circulation
Show All
- Source
- Cite
- Save
Citations (39)